Neuroblastoma: all 634 studies

Page 3 of 7. Open to participants first (122), then studies with results posted, then the rest; newest registration first within each.

• Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNCT01154816Phase 2Results posted
• A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBCompletedNCT01125800Phase 1/2Results posted
• Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory NeuroblastomaCompletedNCT01114555Phase 2Results posted
• Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With EtoposideCompletedNCT01059071Phase 1Results posted
• A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)TerminatedNCT00960063Phase 1Results posted
• A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine TumorsTerminatedNCT00947167Phase 2Results posted
• Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaCompletedNCT00939770Phase 1/2Results posted
• Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or NeuroblastomaCompletedNCT00923351Phase 1/2Results posted
• TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaCompletedNCT00867568Phase 1Results posted
• Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT00831844Phase 2Results posted
• Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk NeuroblastomaTerminatedNCT00808899Phase 2Results posted
• Double Cord Blood Transplant for Patients With Malignant and Non-malignant DisordersTerminatedNCT00801931Phase 1/2Results posted
• Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantCompletedNCT00795769Phase 2Results posted
• Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsTerminatedNCT00788125Phase 1/2Results posted
• Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyCompletedNCT00716976Phase 3Results posted
• Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory NeuroblastomaTerminatedNCT00698009Phase 2Results posted
• N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk NeuroblastomaCompletedNCT00659984Phase 2Results posted
• Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantTerminatedNCT00602446Phase 2Results posted
• Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or MedulloblastomaCompletedNCT00601003Phase 2Results posted
• Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9TerminatedNCT00582608Not applicableResults posted
• Protracted Etoposide During Induction Therapy for High Risk NeuroblastomaCompletedNCT00578864Phase 2Results posted
• Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaCompletedNCT00567567Phase 3Results posted
• Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk NeuroblastomaTerminatedNCT00539500Phase 2/3Results posted
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
• A Study of Pemetrexed in Children With Recurrent CancerCompletedNCT00520936Phase 2Results posted
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With NeuroblastomaCompletedNCT00499616Phase 3Results posted
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
• ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00436852Phase 2Results posted
• Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantCompletedNCT00408681Not applicableResults posted
• Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive CancerCompletedNCT00357500Phase 2Results posted
• Irinotecan and Temozolomide in Treating Young Patients With Recurrent NeuroblastomaCompletedNCT00311584Phase 2Results posted
• Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantCompletedNCT00309907Phase 2Results posted
• Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantCompletedNCT00293384Not applicableResults posted
• N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk NeuroblastomaCompletedNCT00253435Phase 2Results posted
• Use of Rituximab in Opsoclonus-Myoclonus in Children With NeuroblastomaTerminatedNCT00202930Phase 2Results posted
• Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or NeuroblastomaCompletedNCT00098865Phase 2Results posted
• hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory NeuroblastomaCompletedNCT00082758Phase 2Results posted
• Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With NeuroblastomaCompletedNCT00072358Phase 2Results posted
• Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With NeuroblastomaCompletedNCT00033293Phase 3Results posted
• Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With NeuroblastomaCompletedNCT00026312Phase 3Results posted
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsCompletedNCT00024258Phase 2Results posted
• A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With NeuroblastomaCompletedNCT07833631
• Fecal Microbiota Transplant for Neuroblastoma in a Single PatientNo longer availableNCT07223606
• PHOX2B PC-CAR T Cells for Relapsed NeuroblastomaActive, not recruitingNCT07007117Phase 1
• Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing SarcomaCompletedNCT06851221Not applicable
• Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large ModelsCompletedNCT06822842
• Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
• A Study Of Naxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory NeuroblastomaCompletedNCT06438614Phase 2
• PediCARE Health Equity Intervention in High-Risk NeuroblastomaWithdrawnNCT06335745Not applicable
• A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory NeuroblastomaWithdrawnNCT06308575Phase 2
• 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous SystemWithdrawnNCT06233903Phase 2
• Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid BlastomaCompletedNCT06190574
• Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for NeuroblastomaWithdrawnNCT06182410Phase 2
• A Study of Avutometinib for People With Solid Tumor CancersActive, not recruitingNCT06104488Phase 1
• Multi-modular Chimeric Antigen Receptor Targeting GD2 in NeuroblastomaActive, not recruitingNCT05990751Phase 1
• Phase 1 Study of BCD-245 in Subjects With NeuroblastomaStatus unknownNCT05782959Phase 1
• Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsTerminatedNCT05429502Phase 1
• Rapid Administration Pilot for Infusing DinutuximabActive, not recruitingNCT05421897Phase 2
• Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid TumorsCompletedNCT05302921Phase 2
• Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their FamiliesCompletedNCT05245123
• A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsCompletedNCT05199584Phase 2
• Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in ChildrenStatus unknownNCT05179850
• 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young AdultsNo longer availableNCT05064306
• Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.CompletedNCT05027386Phase 1/2
• A Study of N9 Chemotherapy in Children With NeuroblastomaActive, not recruitingNCT04947501Early Phase 1
• Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.WithdrawnNCT04909515Phase 2
• Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid TumorStatus unknownNCT04864821Early Phase 1
• Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical StudyStatus unknownNCT04842526Phase 2
• PEACH TRIAL- Precision Medicine and Adoptive Cellular TherapyActive, not recruitingNCT04837547Phase 1
• Open-Label Study of 18F-mFBG for Imaging NeuroblastomaCompletedNCT04724369Phase 3
• TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of TemozolomideCompletedNCT04610736Phase 1
• Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST TrialSuspendedNCT04539366Phase 1
• Naxitamab and GM-CSF in People With NeuroblastomaNo longer availableNCT04501757
• Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI StudyWithdrawnNCT04500548Phase 1
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT04483778Phase 1
• Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")CompletedNCT04474678Not applicable
• Study on Sintilimab in Stage IV High Risk NeuroblastomaStatus unknownNCT04412408Early Phase 1
• Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsActive, not recruitingNCT04337177Phase 1
• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory NeuroblastomaActive, not recruitingNCT04301843Phase 2
• A Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab BetaActive, not recruitingNCT04253015
• 9-ING-41 in Pediatric Patients With Refractory Malignancies.TerminatedNCT04239092Phase 1
• GVAX Plus Checkpoint Blockade in NeuroblastomaTerminatedNCT04239040Phase 1
• NK Cells Infusions With Irinotecan, Temozolomide, and DinutuximabActive, not recruitingNCT04211675Phase 1/2
• A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory NeuroblastomaActive, not recruitingNCT04106219Phase 1
• Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
• DNA Vaccination Against NeuroblastomaStatus unknownNCT04049864Early Phase 1
• An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsActive, not recruitingNCT04040088Early Phase 1
• 67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory NeuroblastomaTerminatedNCT04023331Phase 1/2
• Dynamic Whole Body Positron Emission Tomography/Computed Tomography ImagingStatus unknownNCT04017104
• MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) MelanomaCompletedNCT03979651Not applicable
• Pediatric Long-Term Follow-up and Rollover StudyActive, not recruitingNCT03975829Phase 4
• A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.CompletedNCT03966651Phase 1
• Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]CompletedNCT03686566
• 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory NeuroblastomaNo longer availableNCT03649438
• C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Active, not recruitingNCT03635632Phase 1
• EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT03618381Phase 1
• DOTATOC PET/CT for Imaging NET PatientsActive, not recruitingNCT03583528
• A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma SubjectsStatus unknownNCT03561259Phase 2
• Investigating the Microbiome and Volatile Organic Compound Profile of Children With NeuroblastomaStatus unknownNCT03545542Not applicable
• 18F-Fluorodopamine PET Studies of Neuroblastoma and PheochromocytomaActive, not recruitingNCT03541720Early Phase 1

← Neuroblastoma overview